Human HI and core histone genes comprise a set of genes that reside in multiple, polymorphically arranged clusters (1-4) located on at least three different riiirnn vsmxn (5) (6) . Coordinate expression of cell cycle regulated human HI (7) (8) and core histone (7) (8) (9) (10) (11) (12) genes is temporally and functionally coupled to the process of CNA replication during S-phase, and histone mFNA abundance is regulated at both transcriptional and post transcriptional levels (reviewed in [13] [14] . Transcriptional regulation involves a 3 to 5 fold transient enhancement of the rate of histone gene transcription at the Gl/Sphase boundary over a basal rate that continues throughout the cell cycle (10, 12) .
The mechanisms governing transcripticnal control of human histone gene expression, as exemplified by cell cycle dependent human H4 and H3 histone genes, have been puJjtid both jjj vivo and in vitro by a variety of techniques (15) (16) (17) (18) (19) (20) (21) (22) . This work revealed that the S-phase specific increase in H4 histone gene transcription rates is accompanied by significant, reversible alterations in chromatin iirij^ii<7jrHnr) of the H4 histone gene promoter (15) (16) .
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Transcription studies performed jjj vivo (17) (18) (19) and in vitro (20) have delineated proximal and nint^i pi • nt ii e*r elements implicated in the regulation of human H4 histone gene transcription. The proximal promoter elements of this gene have been correlated with two da/protein interaction sites that are detected both in vivo (21) and in vitro (22) and at least three distinct factors involved in these interactions have been partially purified (22 and unpublished data) . JJD vitro studies performed by other workers have yielded interesting data on the transcrlptional regulation of two other human care histone genes (23) (24) (25) , but equivalent information is not available far human HI histone genes.
Coordinate expression of multiple HI and core histone genes in tight conjunction with CNA synthesis is a phenomenon that is not well understood, although it is conceivable that a ninimn mechanism underlies the regulation of these genes (7) (8) . Transcrlptianal regulation in general is mediated, at least in part, by ENA binding proteins that bind to distinct promoter elements (26) . Thus, control at this level may require regulatory factors that are involved in coordinating histone gene transcription during the cell cycle. Although many promoter elements (18) (19) (20) (21) (22) (23) (24) (25) and various nuclear factors have been characterized so far (22) (23) (24) , none of the factors has been studied in sufficient detail to unequivocally establish a role far these factors (or their cognate cis-acting elements) for coordination and S-phase specific enhancement of transcription as observed in vivo.
In this work we have established the functionality of the 5' flanking region of a cell cycle dependent human HI histone gene designated FNO.6 (1) by SI nicleaae protection analysis and determined the ENA sequence of a 0.5 kB fragment preceding the gene. By using a variety of sequence specific LHA/protein binding assays we have characterized two target sites for protein binding in the HI histone gene pnwitpir and partially purified the factors involved. Together, these results enable us to make a comparative analysis of factor binding sites in both HI and core human histone gene promoters and to frnnt%f\tf-a a working nnrfc»i for the coordinate transcrlptional regulation of human HI and core histone genes.
MMBRIAIS AND METHX6
The human HI histone gene was derived from a genomic histone gene cluster cloned into lambda Charon 4A (1) and subdcned into pER322 to generate the plamirtw pFNCL6 and pINC16A (3) . Restriction fragments spanning the 5' region were subclcned into KL3mpl9 and subjected to Sanger dideoxy sequence analysis (27) . Ihe most proximal part of the promoter ENA sequence was confirmed by
Maxam & Gilbert reactions (28) . Plasmid pCDCOOl was prepared by subcloning an upstream Snal/PvuH fragment of pFNCL6A into Bluescript RS(KL3+) (Stratagene).
Nuclear extracts and fractionation
Preparation of nuclear extracts (NE) and fractionation of these by CEAESephacel and phosphocellulose column chromatography was performed as decribed before (22) , with the following exceptions. Freshly prepared nuclei from 8 X 10 9 exponentially growing Hela S3 cells were washed once with 50 ml sucrose buffer (50 mM Hepes-NaCH, pH 7.5; 10 % sucrose) and extracted with the same buffer containing 400 mM RC1. Nuclear extracts were diluted to a concentration of 200 mM KC1 (50 ml, 140 ng protein) and passed over a DEAE-Sephacel column 
SI nuclease protection analysis
Isolation of total cellular SNA from HeLa S3 cells synchronized by double thymidine block (10) and SI nuclease protection analysis (18) were performed as described before. S-phase FNA and ENA outside of S-phase were isolated from nt>T\a at 5 hr and 11 hr respectively after release from the block. After treatment of cells for 1 hr with lmM hydroxyurea, ENA was isolated from cells harvested 4 hr after release. The CNA probe used in these experiments was an end labelled Pvun/StuI fragment (size 731 nt) which yields a piutecteri fiflqiwnt of 260 nt (Fig. 1) . The site of nHNA initiation was determined using an end labelled PVUH/BCU fragment (size 680 nt) which yields a protected fragment of 199 nt (unpublished data).
Gel retardation assays and stairway assays
ELectrophoretic mobility shift assays (gel retardation assays) and reciprocal restriction site deletion analysis (stairway assay) were performed as described (22) , with the amuuiit and type of competitor CNA indicated in the figure legends. The CNA probes used in this study to detect CNA/protein interactions in vitro were restriction fragments derived from plasmid pOKOOl that were single end labeled at a Smal-site (nt -78) or at a Psal-site (nt-223) (Fig. 1 ENAsel protection experiments were performed by making a 25-fold scaled up binding reaction as above, Incubating the sample with 5u ENAsel (Boehringer) far 1 minute at room temperature and stopping the reaction by adding EDIA to a final concentration of 25 mM. Preparative separation of unbound probe and bound ENA/protein complexes by electrophoresis was followed by excision of the bands from the gel and elutlon by diffusion (27) . After processing of the eluate the samples were analyzed on a denaturing 8% polyacrylamlde gel containing 7M urea. EM3 protection studies were done in a similar fashion with the exception that pulse incubation occurred by adding 2.5/JI undiluted dimethylsulphate (EMS) and that no EXTCft was added. After elution samples were treated with piparidine and guanine specific cleavage products were analyzed on gels (28) . Methylatlon interference (29) was performed by Incubation of the probe with EMS prior to the binding reaction. After removal of the EMS, the partially methylated probe was incubated with protein fractions and then the bound and unbound EKA fragments were separated by preparative gel electrophoresis. Subsequently, the samples were treated in the same way as far EMS-protection studies.
Ths frflipfl*n HI hlstone gene fHd6 is functional and expressed In vivo
The extent to which expression of a cloned human HI hlstone gene designated JNC16 (Fig. 1 hybridization with other HI histone niFNAs made it uncertain that the FNO.6 Hi histone gene itself is expressed in a cell cycle dependent manner. In addition, functional copies of human histone genes are clustered with highly homologous, non expressed pseudo-genes (30) , raising the possibility that the HI histone gene FNO.6 could be non-functional. therefore, we investigated the expression of the HI histone gene FNOL6 by SI nuclease protection analysis of the PNAs isolated from synchrcnized Hela S3 cells (Fig. 2) . The probe used far these experiments was a 731 nt Pvun/StuI fragment of pFNC16, which includes 5 1 flanking sequences and the initial coding sequences of the HI histone gene (Fig. 1 ) FNA isolated at the peak of S-phase ( Fig. 2 ; ln 1-2) protected a 260 nt fragment of this probe from SI nuclease digestion. The protected fragment is distinguishable from other SI nuclease degradation products that can arise from hybridization of pFNd.6 with homologous nSNA species. Very limited SI protection occurs with BNA isolated from eelIn outside S-phase ( Fig. 2 ; In 3-4) or by S-phase FNA from cells treated with the ENA synthesis inhibitor hydraxyurea ( Fig. 2 ; In 5-6). Outlined with previous work (10, 11) , this result establishes that the HI histone gene FNCL6 is a bona fide cell cycle regulated gene with expression tightly coupled to ENA replication. located more upstream from the above consensus elements are two perfect copies of a putative HI specific consensus element (AAACACA-box; nt -173 to -167 and nt -282 to -276) (31) . In addition, three A/T-rich repeats (between nt -198 to -185) can be observed; similar elements in the promoter of cell cycle dependent human H4 and H3 histone genes have been inplicated in the binding of a factor designated HiNF-A (22) . Another remarkable feature is an imperfect 20 bp repeat containing a Dral-site, starting at positions nt -323 and nt -430 respectively. Fran all of the above observations we inferred that the region between nt -60 to -200 is analogous to the upstream region between nt -50 to -150 of the cell cycle regulated H4 histone gene F0108 (21) that contains two major in yj,yj2_CNA/protein interaction sites.
Four ENA/protein conplexes can ba formed in the Hi histone promoter region in vitro
The gal retardation assay has been used to study EKA/protein interactions in the human HI histone promoter in vitro in order to detect factors that are analogous or identical to ENA binding i rarwrrrlpHnn factors observed for care H4 and H3 histone gene promoters. The probes used cover the region nt -233 to -78; this region contains at least one copy of all the consensus ENA elements mentioned above. In an initial experiment an end labelled SSnal/AluI restriction fragment (spanning nt -233 to -78) was incubated with increasing amounts of crude Hela nuclear extract protein in the presence of either poly I/C ENA or E. coli ENA. Upon electrophoresis of the mixtures containing E. coli ENA in a low ionic strength, native polyacrylainide gel, two praninent retarded ENA fragments (designated complex A and complex B) were observed ( Fig. 4 ; In A1-A9). However, if poly I/C ENA was used as competitor ENA, only the upper retarded fragment (complex B) and two other retarded fragments (designated complex C and complex D) were detectable ( Fig. 4 ; In B1-B9). Apart from the above mentioned ENA/protein complexes we observed an additional complex slightly above complex B (not indicated). Similar satellite bands are also associated with major H4 and H3 histone praBoter/protein complexes (unpublished observations). In these cases, formation of such ENA/protein complexes requires the same ENA sequences and the factors involved elute in the same fractions; this suggest that satellite bands are formed by closely related factors. The factor involved in the satellite band of complex B meets similar criteria (see Fig. 4 and 5; not indicated).
Complex B displayed an intensity not previously observed far any of the probes used in our gel retardation assays (22 and unpublished data) suggesting that the factor bound to the probe is relatively abundant and/or has a high affinity for the HI histone gene promoter. Ornylexes C and D could represent separate nuclear factors and/or oligomerization states of factors present in complex B or complex A.
Complex A showed similarities in relative migration rate and intensity with a complex formed by a factor designated HiNF-A (see previous section) that binds to H3 and H4 histone gene promoters. In addition, as is the case here, binding of HiNF-rA to these promoters was not detected when poly I/C ENA was included in the binding reaction, suggesting that the factor interacting with the human HI histone gene promoter is similar or identical to HiNF-A.
Nuclear extracts have been fractionated by liquid column chromatography on EEAE-Sephacel and phosphocellulose in order to separate the ENA binding activities that associate with human histone gene promoters and to obtain qualitative data on the physical properties of these factors. Ocnplex A formation was analyzed using the same protein fractions by including poly I/C ENA in stead of E. coli ENA in the binding reaction. Formation of ocnplex A was observed with the P350-1000 fraction ( Fig. 5B ; In D1-D6), but not with the other phospnocellulose fractions ( Fig. 5B ; In B1-B6 and CL-C6). The detection of complex A in the P35O-1OO0 fraction in the presence of E. coli ENA, but not poly 1/C ENA (see Fig. 5A ; In FJ.-2), again suggests that the factor involved in formation of complex A is similar or identical to HiNF-^A. Because this factor fits the current operational definition for HiNF-A we have given it the gam> designation, although it could be that HiNF-A is a collection of closely related factors.
In summary, we have detected at least two distinct factors (HiNF-A and HiNF-B) involved in the formation of two prominent ENA/protein complexes (complex A and complex B). Moreover, our results indicate another DNA/protein ocnplex that may be related to factor HiNF-B (complex C), but probably not HiNFrA, and a complex that may be unrelated to either factor HiNF-A or factor HiKF-B (complex D). binds to a distal piuuuter seumaiL containing AT-rich repeats Reciprocal restriction site deletion analysis in combination with the gel retardation assay ("stairway assay") was used to fine map the segment in the human HI nistone promoter involved in formation of complex A (Fig. 7A and 7B ). Restriction fragments labelled either at a anal site (nt -76) or at a Rsal site (nt -213) were prepared and shortened by various restriction enzymes as indicated in the figure legends; these probes were used in parallel in gel retardation assays. Incubation of shortened puJjtaj labelled at the anal site with P35O-10O0 protein resulted in formation of complex A when sequences up to an Rsal site were deleted ( Fig. 7 ; In HL-B6), but not when sequences upstream of an Hinfl site were omitted, showing that sequences between the Rsal site and the Hinfl site (nt -213 to -160) are required for ocsqplex A formation. The reciprocal experiment was carried out in which the various probes were labelled at the Rsal site ( Fig. 7; In A1-A6) . Binding reactions performed with these pnJjeti in the presence of P350-1000 protein revealed that sequences downstream of a Hinfl site (nt -160) are dispensable for factor binding and that the Ksal/Hinfl fragment (54 bp) by itself is capable of binding the factor, thus, we have identified a EKA segment (nt -213 to -160) that is both required and sufficient for binding of HiNF-A. Inspection of the ENA sequence of this firtijiiriit shows that it contains two direct and one inverted repeat of an ATTT-elenent. Similar repeat elements have been shown to bind HiNF-rA in human H3 and H4 histone promoters (22) . Therefore, the assignment that ccmplex A in the HI histone promoter is formed by HiNF-A or a related factor is consistent with these findings.
binds to the roost prcocirpal promoter seguenoes Stairway assays were also used to localize the binding domain far HiNF-B in the HI histone promoter. Probes labelled at the Smal site were incubated with a fixed amount of protein and analyzed on gel ( Fig. 7C and D) . Deletion of sequences upuLmTm of a HaeTTT site (nt -138) had no effect on formation of complex B and a Haem/Smal fragment by itself was sufficient far binding of HiNF-B ( Fig. 7 ; In C1-C4, D0-200 fraction, and In C5-C8, P0-200 fraction). Hence, we have delineated a 53 bp fragment (nt -138 to -76) that is sufficient for binding of HiNF-B.
Reciprocal probes labelled at the Rsal sites were also analyzed in the assay. In accordance with the results presented above, only a Rsal/Smal fiacjiuaiL yields substantial complex B formation, although residual binding is still observed with a Rsal/Hinfl fragment ( Fig. 7 ; In D1-D3). The latter suggests the presence of an additional, low affinity binding site far HiNF-B in the 3' portion of the probe between nt -213 and -160. The results obtained for complex C (Fig. 7 ; In C1-C4 and D1-D3) do not seen to be compatible with a single binding domain for a unique factor. This complex is detected only when a substantial amount of complex B is farmed, further suggesting that rrrpiov B and C are related. Factor HiNF-B is a PuOCAAT-box bindlra protein
The CKA segment (nt -138 to -76) involved in binding of HiNF-B contains three consensus transcriptional elements (see previous section) necessitating a more detailed analysis of the exact HiNF-B binding site. This was by ENAsel footprint analysis in which HI probes end-labelled at the top (sense/+) or button (anti sense/-) strand were incubated with DO-200 protein fraction and mixtures pulse digested with ENAsel (Fig. 8A) . Separation of court ax B from unbound ENA and unstable DNA/protein complexes (background smearing on gels) was accomplished by native polyacrylamide gel electrophoresis. The radioactive ENA in the gel segments corresponding to complex B (bound DNA) or unbound DNA was analyzed by denaturing gel electrophoresis. Using this approach, the min-imai boundaries for protection by HiNF-B against DNAsel phcephodiester cleavage were established at nt -120 and -92 on the top (+) strand and between nt -121 and -90 on the bottom strand (Fig. 8A) , although differences were detected in the extent to which HiNF-B prevents accessibility of DNAsel to particular residues within the HiNF-B binding site. The ENA sequence of this DNAsel footprint contains a perfect PuCCAAT motif, but lacks the other consensus elements. Therefore, we conclude that HiNF-B is a PuCCAAT-box binding protein (see Discussion). In addition, the HiNF-B footprint extents further towards the 3 1 side of the PuOCAAT-box and terminates at the first nudeotides of a palindromic TATA-element which may have important biological Implications (see next section). No protection was observed for an inverted PuOCAAT-box located at nt -119 to -124 despite the fact that this element is present at a distance from the protected PuCCAAT-box that would not prohibit dimerization of two single PuOCAAT-box factors (33, 34) . Taking into account that HiNF-B is a two ounxjuaiL factor it is for this reason unlikely that HiNF-B is a dimer of a single OCAAT-booc factor. Contact paint analysis of the The interaction of HiNF-B with its binding site was studied at single nKfl.eot.lde resolution by EHS fingerprinting in order to define points of close contact between HiNF-B and the guanine bases within its DNA recognition sequence. This approach, which measures the inaccessibility of purine-residues to methylation by dimethylsulphate during the binding reaction (Fig. 8B) , was neccessary in order to confinn the presence of PuCCAAT-box specific DHA/protein contacts and to uncover possible additional contacts within the footprint. To this end, the bottom (-) strand, containing the majority of G-residues within the footprint, was end labeled and this double stranded HI probe was preincubated in the presence of the. DO-200 fraction and then treated with OB in a manner similar to that used for EHAsel footprinting experiments.
EMS treated samples derived from the DNA fraction representing complex B (bound) showed reproducible protection of G-residues nt -111 and -110, the complementary nudeotides of the PuQCAAT-box, and detectable hypomathylation of G-nucleotide -99, localized in the 3• side of the DNAsel footprint. Occasionally, we observed faint protection of G-104 by comparing the intensity ratio of this G with the unprotected residue G-106. We noted a very strong enhancement of methylation of G-residue nt -113 suggesting that binding of HiNF-B makes this nucleotide highly accessible to OG attack. In conclusion, the EMS protection pattern is compatible with the assignment of HiNF-B as a PuOCAAT-box binding protein, but the presence of additional contacts in the 3 1 side of the ENAsel footprint supports the idea that a second DA binding activity is present, that binds in conjunction with the PuOCAAT-box factor.
The binding site of HiNF-B was studied in further detail by EMS methylation interference experiments. These studies were carried out to assess whether the methylaticn of certain G-residues by CMS treatment prior to the binding reaction, interfered with binding of HiNF-B (Fig. 8B) . Again, the bottom (-) strand was end-labelled, the CfCV fragment conplexed to HiNF-B and the radioactive ENA fractions (bound and unbound) were isolated in the same way as in the above experiments. The results obtained showed clearly that methylation of G-residues nt -111 and -110, but no other G-residues, abolished binding because the corresponding bands were missing in the G-specif ic piperidine cleavage pattern of the bound fraction and were significantly enriched in the uncomplexed ENA fraction. Because EMS methylates G-residues at the major groove of the ENA helix, the data derived from the CMS fingerprinting and EMS methylation interference experiments demonstrate that HiNF-B binds in close proximity to the major groove of the PuOCAAT-bax (Fig. 9 sumnarizes the above data). However, no interference occurred at any of the other G-residues within the bottom strand implying that the methylation protection and methylation enhancement of the G-residues peripheral to the PuOCAAT-box are caused by tunneling and shielding effects intrinsic to the physical surface of the bound factor.
Vertebrate histone gene promoter ENA sequences (31) were searched for similarity with the EHA sequence contained within the HiNF-B footprint. This analysis showed that the HiNF-B binding site contains the Breathrach/Oianban OCAAT-consensus sequence (35) , but in histone gene promoters the homology extents further; the consensus CCAAT-element for histone gene promoters is 5•dPyPyPuPuOCAAT(Q/G)APuPuPu. nrtri-«Tative analysis of human HI and core H3 and H4 histone gene promoter ENA elements and protein binding sites
The promoter regions of three cell cycle dependent human histone genes (HI, H3 and H4) have been investigated far ENA/protein interactions and, in total, we have detected at least six CNA/protein interaction sites in vitro (22 and unpublished data) some of which have been shown to overlap jjj vivo protein binding sites (21) ; a sunmary of these findings is shown in Figure 10 . Factor HiNF-A appears to have binding sites in all three histone gene promoters examined and protection of its binding site in the H4 histone gene promoter histone gene. HiNF-A is a protein that causes slight retardation of CNA fragments containing its binding site in gel retardation assays, suggesting that it is a rather snail protein.
The factor is present in the high salt phosphooellulose fraction of a nuclear extract which represents a nan part of total nuclear protein. The binding of HiNF-A is undetectable in the presence of low amounts of poly I/C CNA, but is relatively resistant to competition by E. coli CNA in gel retardation assays suggesting that poly I/C CNA has certain features that resemble its binding site. The factor has a sequence specific CNA binding activity as has been demonstrated, for instance, by stairway assays and CNAsel foctprinting (22) .
Thus far, the only documented protein that resembles HiNF-A in some aspects is mouse alpha protein (36); this protein is comparably small, elutes in a similar high salt phosphooellulose fraction, is competed out specifically with poly I/C CNA but not with other synthetic CNA substrates and recognizes a series of apparently random A/T rich sequences. The latter property is the only feature that does not seem to be shared between alpha protein and HiNF-A; rather, HiNF-A appears to bind to raraii repeated ATTT-elanents that are present at comparable locations in the three histone gene promoters we have investigated to date. So far, we have not been able to detect a direct role for the protein in transcription in vitro (K. Wright, unpublished data), although the conserved location of its site in both human HI and care histone gene promoters and detection of its protected site in vivo (21) suggest an important biological role. The similarity of HiNF-A with nouse alpha protein may extent further; for instance, the latter protein is implicated in rnml positioning. In viewing the cell cycle dependent changes in i<iniiwHn structure that occur in the histone gene promoter during S-phase (15, 16) this leaves open an attractive possibility for a function of HiNF-A that can not be addressed easily by in vitro studies.
HiNF-B has been shown in this work to bind to a well conserved PuCCAATmotif in the human HI histone gene FNC16 that is present in a number of other histone gene promoters (31) as well as a broad spectrum of vertebrate promoters (26) . A number of PuOCAAT-bcoc binding proteins (CBP) have been described to date among which are mouse alpha globin CBP (ag-CHP) (37), Herpes simplex virus thymidine kinase CBP (tk-CBP) (38) , human NF-I (39), vertebrate NF-I/IGCCAbinding proteins (40) and human NF-I/CTF (41) . The latter three factors are independent CBP isolates from several different laboratories characterized initially by their ability to stimulate Adenovirus CNA replication (39) , but later shown to be analogous or identical to the CCAAT transcription factor (CTF) (41) .
Our HiNF-B/CHP seems different from tk-CBP in that our factor is heat sensitive (32; discussion in 41) and different from tk-CBP and CTF/NF-I in ENAsel footprint size: HiNF-B has a footprint that extends more to the 3 1 side of the PuCCAAT-element, a property shared with (heat sensitive) ag-CBP (37) .
Comparison of the contact points of the PuOCAAT binding site with HiNF-B, ag-CBP (37) or NF-I (34) shows that the same G-residues are protected against dimethylsulphate; although we have found additional protection and enhancement of G's in the HI histone promoter, these G-residues are not present at carresponding positions in the other sites investigated (34, 37) . Moreover, our methylation interference studies using HiNF-B have shown that analogous methylated G's in the HiNF-B and NF-I site (34) prohibit binding. We conclude that human HiNF-B, mouse alpha globin CBP and human NF-I have similar contact points with their cognate sequence, although their ENAsel footprints seem to show discrepancies.
Factors resembling HiNF-A and HiNF-B can be isolated from mouse cells (32) , suggesting that mouse ag-CBP and human HiNF-B could be protein homologues.
Comparison of the chramatographic behavior of ag-CBP and HiNF-B shows that the former elutes in the phosphocellulose flow through (100 mH ¥d) (37) . In contrast, HiNF-B exhibits extensive dissociation in a similar flow through fraction (200 mM KC1) into at least two components Bl and B2. A similar comparison between NF-I and HiNF-B reveals that NF-I elutes at 350 mM NaCL, with a minor peak of activity at 450 roM NaCL (39) . Such data show that these factors are physically different. However, because HiNF-B is a two component factor the possibility must be considered that one of these components resembles other CBP's when separated from the second. In conclusion, HiNF-B appears to be a new member of a growing class of PuCCAAT-box ENA binding proteins.
The promoter regions of cell cycle regulated human HI and core H4 and H3 histone genes cloned in our laboratory have been studied in detail both in vivo and in vitro (15-22, 32, 42 and this work). One picture that is emerging from these studies is that coordinate transcrlptianal control of histone gene expresssion may be exerted by a complex combination of three classes of transacting factors: (I) multiple, general transcription factors that bind to subsets of histone promoters in conjunction with both (H) histone specific factors, and possibly (m) less general, cell cycle stage specific factors. This notion is in agreement with the working model of Heintz and collaborators (25) that is based on sequence homology between two (H2B and H4) core histone gene pranoters. Regardless of the interrelationship between the various factors and their cognate promoter elements identified so far, the rigorous purification of histone promoter specific DNA binding activities by DNA affinity chronatography is a pre-requisite in addressing the validity of any transcriptiron! regulation model. This work was supported by grants from the National Institute of Health (GM 32010, Ot 32381), the National Science Foundation (PCM 83-18177) and the March of Dimes Birth Defects Foundation (1-183). AJvW and MS are recipients of an exchange program grant from the University of Utrecht, Netherlands, under the supervision of Dr. Harry Voarma. We thank Wesley Faunce for performing initial experiments and Drs. Harry Nick, Peter van der Vliet and Erik de Vries for advice and materials. Special thanks to Urs Paul! and Susan Qirysogelos far critical discussions.
